1. Home
  2. SLNO vs MHO Comparison

SLNO vs MHO Comparison

Compare SLNO & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • MHO
  • Stock Information
  • Founded
  • SLNO 1999
  • MHO 1976
  • Country
  • SLNO United States
  • MHO United States
  • Employees
  • SLNO N/A
  • MHO N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MHO Homebuilding
  • Sector
  • SLNO Health Care
  • MHO Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • MHO Nasdaq
  • Market Cap
  • SLNO 3.2B
  • MHO 3.1B
  • IPO Year
  • SLNO 2014
  • MHO 1986
  • Fundamental
  • Price
  • SLNO $73.35
  • MHO $106.57
  • Analyst Decision
  • SLNO Strong Buy
  • MHO Strong Buy
  • Analyst Count
  • SLNO 9
  • MHO 3
  • Target Price
  • SLNO $103.33
  • MHO $158.67
  • AVG Volume (30 Days)
  • SLNO 744.8K
  • MHO 211.1K
  • Earning Date
  • SLNO 05-07-2025
  • MHO 04-23-2025
  • Dividend Yield
  • SLNO N/A
  • MHO N/A
  • EPS Growth
  • SLNO N/A
  • MHO 9.13
  • EPS
  • SLNO N/A
  • MHO 18.93
  • Revenue
  • SLNO N/A
  • MHO $4,434,060,000.00
  • Revenue This Year
  • SLNO N/A
  • MHO $0.74
  • Revenue Next Year
  • SLNO N/A
  • MHO $0.62
  • P/E Ratio
  • SLNO N/A
  • MHO $5.63
  • Revenue Growth
  • SLNO N/A
  • MHO 8.69
  • 52 Week Low
  • SLNO $36.93
  • MHO $100.22
  • 52 Week High
  • SLNO $80.99
  • MHO $176.18
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 49.78
  • MHO 44.80
  • Support Level
  • SLNO $72.29
  • MHO $105.74
  • Resistance Level
  • SLNO $78.32
  • MHO $109.84
  • Average True Range (ATR)
  • SLNO 2.74
  • MHO 3.04
  • MACD
  • SLNO -0.57
  • MHO -0.28
  • Stochastic Oscillator
  • SLNO 27.11
  • MHO 18.72

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: